美托洛尔治疗慢性心力衰竭疗效观察
摘要
2004年1月至2008年1月，我院心血管内科对部分慢性心力衰竭患者采用美托洛尔（倍他乐克）治疗，观察到对改善患者的心功能有明显作用，现总结并报道如下：
二级参考文献21
-
1Tang WHW, Vagelos RH, Yee YG, et al. Neurohormonal and clinical responses to high-versus low-dose enalapril therapy in chronic heart failure. J Am Coll Cardiol,2002,39:70-78.
-
2CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandanavian enalapril survival study. N Engl J Med, 1987,316:1429-1435.
-
3Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med, 1996,334:1350-1355.
-
4Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan comparaed with captopril on mortality in patients with symptomatic heart failure: randomized trial the Losartan Heart Failure Survival Study ELITE-Ⅱ. Lancet, 2000,355:1582-1587.
-
5Cohn JN. Improveing outcomes in congestive heart failure: Val-HeFT Valsartan in Heart Failure Trial. Cardiology, 1999,91(Suppl 1):19-22.
-
6Pfeffer MA, McMurray JJ, Velazquez EJ,et al. Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med, 2003,349:1893-1906.
-
7Pitt B."Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotension converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther, 1995,9:145-149.
-
8Pitt B, Zannad F,Remme WJ, et al. The effect of spironolactone on morbidity and mortility in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Eng J Med, 1999,341:709-717.
-
9Packer M, Cohn JN, Abraham WT, et al. Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83(2A):1-38.
-
10Pitt B, Remme W, Zannad F, et al.For the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med,2003, 348: 1309-1321.
共引文献2446
-
1杨晶,保成英,樊金花,周泉.明尼苏达心衰生存质量量表在慢性心衰患者个体化护理中的应用效果[J].青海医药杂志,2022,52(3):21-24. 被引量：5
-
2李玉梅,胡金萍.中医护理模式应用于慢性心力衰竭患者的效果观察[J].青海医药杂志,2020(9):35-37. 被引量：2
-
3蔡楠.应用中医护理方案结合心脏康复治疗对改善慢性心力衰竭患者生存质量的效果观察[J].世界最新医学信息文摘,2019,0(75):232-232. 被引量：3
-
4王官凤,刘士兰,许诺.美托洛尔联合坎地沙坦治疗充血性心力衰竭62例疗效观察[J].中国基层医药,2014(S01):34-35. 被引量：1
-
5徐春太,杨学萍.美托洛尔对收缩性心力衰竭心室重塑及心功能的研究[J].临床研究,2014,22(8):70-71.
-
6罗铭霞.冠心病引起的心力衰竭与风湿性心脏病引起的心力衰竭治疗后恢复情况分析[J].医学信息（医学与计算机应用）,2016,29(28):261-262.
-
7王丹.急性心肌梗死静脉溶栓的观察与护理[J].医学信息（医学与计算机应用）,2014,0(23):387-387.
-
8庞善林.老年人慢性心力衰竭的诊断与治疗[J].医学信息（医学与计算机应用）,2014,0(20):469-469.
-
9董智骤,赵海军,倪海霞.蚓激酶对心衰患者心脏彩超指标影响的研究[J].医学信息（医学与计算机应用）,2014,0(20):242-242.
-
10郑永红.坎地沙坦治疗充血性心力衰竭近期疗效观察[J].医学信息（医学与计算机应用）,2014,0(29):22-23.
-
1孙德利,周丽.倍他乐克对心脏的少见影响1例[J].实用心电学杂志,2002,11(6):474-474. 被引量：2
-
2姚原泉,冉中兴,田文庆.卡托普利，倍他乐克联合治疗心力衰竭的疗效观察[J].中华临床医药杂志（北京）,2003,4(10):84-84.
-
3赵赤,孙玉玮,等.倍他乐克及硝苯地平治疗高血压疗效比较[J].吉林医学信息,1998,15(9):2-2.
-
4温京丽.倍他乐克合并硝苯地平治疗高血压病120例[J].武警医学,1999,10(11):635-635. 被引量：1
-
5刘丽波,刘汉利,姜旭红.倍他乐克与硝苯地平治疗原发性高血压30例[J].现代医药卫生,2004,20(7):532-532.
-
6王保振,宋振凤,董金勇.倍他乐克在冠心病心绞痛中的应用[J].新乡医学院学报,1994,11(2):197-198. 被引量：1
-
7丁建东,马春阳.倍他乐克在慢性心力衰竭中的应用[J].江苏临床医学杂志,1998,2(1):24-24.
-
8梁文生,李雪飞.倍他乐克和黄芪注射液联合治疗充血性心力衰竭疗效观察[J].中国医师杂志,2002,4(6):696-697.
-
9俞丽芬.倍他乐克治疗高血压病的临床观察[J].镇江医学院学报,1999,9(1):72-73.
-
10朱建新.卡托普利和倍他乐克联合治疗原发性高血压73例疗效分析[J].苏州医学,2002,25(4):178-178.
